Dawaa Reference

Clinical reference

Bladder cancer

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

Bladder Cancer - StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK536923/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class UD26 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (4)

  • Blood in the urine, seen or found only on testing, is the most common first symptom [blood in the urine]
  • Over a third of patients with visible blood in the urine are eventually diagnosed with bladder cancer [blood in the urine]
  • Painful urination, urinary frequency, a pelvic mass, fatigue, or weight loss occur less often [burning on passing urine · fatigue · pelvic mass · urinary frequency · weight loss]
  • A smoking history of at least 10 pack-years meaningfully raises bladder cancer risk

Signs — what you find (1)

  • In women, the external genitalia, introitus, and area around the urethra are inspected closely

Tests (7)

  • Low-risk status requires urinalysis with 10 or fewer red cells per high-power field and no prior hematuria
  • Urinalysis showing more than 25 red cells per high-power field marks high risk
  • CT urogram is the gold-standard imaging test for the upper urinary tract
  • Cystoscopy is the gold-standard initial test, with roughly 98% sensitivity
  • Non-muscle-invasive tumors look like frond-like growths with fine vessels that bleed easily
  • Carcinoma in situ looks like a flat, irregular red patch easily mistaken for plain inflammation
  • Urine cytology is only about 44% sensitive despite 96% specificity

If not this — what else fits (5)

  • Benign prostatic hyperplasia or bladder wall thickening from obstruction or infection can look similar
  • Interstitial cystitis is on the differential list
  • A urinary tract infection can present with overlapping symptoms
  • Kidney stones or an overactive bladder can produce similar symptoms
  • Radiation cystitis or a renal mass are also part of the differential

SourceStatPearls "Bladder Cancer" - disease-level clinical article

Presentation findings are traced to the source above.

1

NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)

1st line
Adult dose and duration

Bladder cancer has a notably higher incidence in Egypt historically linked to schistosomiasis; the GP must recognise painless blood in the urine and refer urgently for urology work-up. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Bladder cancer has a notably higher incidence in Egypt historically linked to schistosomiasis; the GP must recognise painless blood in the urine and refer urgently for urology work-up.

Cautions
  • RED FLAG - Unexplained weight loss or palpable pelvic mass: assess urgently and refer.
  • RED FLAG - Clot retention causing acute urinary retention: assess urgently and refer.
  • Painless visible blood in the urine in an adult, especially with a history of schistosomiasis, is an urgent referral trigger for bladder cancer.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.